Utah Admin. Code R414-71-5 - Service Coverage and Limitations
(1)
Medicaid covers screening and diagnostic services to assess for physical or
mental conditions.
(2) Services
include:
(a) a comprehensive health and
developmental history, including the assessment of physical and mental
development;
(b) dental and oral
health screening;
(c) comprehensive
physical examination;
(d) vision
screening;
(e) hearing
assessment;
(f) speech and language
development;
(g) appropriate
immunizations according to age and health history;
(h) laboratory tests, including blood lead
level assessment appropriate to age and risk; and
(i) health education, including anticipatory
guidance.
(3) When
indicated through medical screening, a Medicaid provider shall provide
diagnostic services.
(4) Medically
necessary services are available for treatment of physical and mental illnesses
or conditions discovered by screening or diagnostic evaluations.
(5) Additional services include:
(a) chiropractic services;
(b) orthodontia;
(c) occupational therapy;
(d) physical therapy;
(e) speech-language pathology
services;
(f) private duty
nursing;
(g) diagnosis and
treatment for vision related conditions, including eyeglasses;
(h) dental services for the relief of pain
and infections, restoration of teeth, maintenance of dental health including
examinations, cleanings, radiographs, and fluoride treatments;
(i) diagnosis and treatment for conditions
related to hearing, including hearing aids; and
(j) additional health care services coverable
under Subsection 1905(a) of the Social Security Act and found to be medically
necessary to treat, correct, or ameliorate illness and conditions discovered
regardless of whether the service is covered in the Medicaid State
Plan.
(6) The department
determines whether a service is medically necessary.
(7) Medicaid does not cover:
(a) reconstructive and cosmetic procedures
described in Section R414-1-29;
(b) services for caregivers or for provider
convenience;
(c) duplicative
services; or
(d) experimental or
investigational treatments except when the member is participating in a
qualifying clinical trial for the prevention, detection, or treatment of any
serious or life-threatening disease or condition as outlined in Section 210 of
the Consolidated Appropriations Act of 2021.
(8) The department may consider the relative
cost effectiveness of alternatives as part of the prior authorization process
described in Section R414-1-2.
Notes
State regulations are updated quarterly; we currently have two versions available. Below is a comparison between our most recent version and the prior quarterly release. More comparison features will be added as we have more versions to compare.
No prior version found.